Bouros I, Hill E, Keeling M, Moore S, Thompson R
PLoS Comput Biol. 2024; 20(8):e1012309.
PMID: 39116038
PMC: 11309497.
DOI: 10.1371/journal.pcbi.1012309.
Xu R, Sun R, Fu S
JMIR Public Health Surveill. 2024; 10:e56054.
PMID: 38771620
PMC: 11150895.
DOI: 10.2196/56054.
Marziano V, Guzzetta G, Menegale F, Sacco C, Petrone D, Urdiales A
Influenza Other Respir Viruses. 2023; 17(8):e13181.
PMID: 37599801
PMC: 10432583.
DOI: 10.1111/irv.13181.
Galli M, Zardini A, Gamshie W, Santini S, Tsegaye A, Trentini F
Sci Rep. 2023; 13(1):5586.
PMID: 37019980
PMC: 10075159.
DOI: 10.1038/s41598-023-32501-y.
Zirkenbach V, Ignatz R, Ottl R, Cehreli Z, Stroikova V, Kaya M
Int J Mol Sci. 2023; 24(5).
PMID: 36902442
PMC: 10002951.
DOI: 10.3390/ijms24055011.
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study.
Fedele G, Trentini F, Schiavoni I, Abrignani S, Antonelli G, Baldo V
Front Immunol. 2022; 13:1021396.
PMID: 36389704
PMC: 9661524.
DOI: 10.3389/fimmu.2022.1021396.
High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz.
Harthaller T, Borena W, Bante D, Schafer H, Strallhofer O, Zoggeler T
Viruses. 2022; 14(10).
PMID: 36298849
PMC: 9609860.
DOI: 10.3390/v14102294.
Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak.
Willeit P, Kimpel J, Winner H, Harthaller T, Schafer H, Bante D
Front Public Health. 2022; 10:989337.
PMID: 36159252
PMC: 9500479.
DOI: 10.3389/fpubh.2022.989337.
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients.
Tsuzuki S, Miyazato Y, Terada M, Morioka S, Ohmagari N, Beutels P
Health Qual Life Outcomes. 2022; 20(1):125.
PMID: 35986269
PMC: 9388960.
DOI: 10.1186/s12955-022-02033-6.
COVID-19 mortality and its predictors in the elderly: A systematic review.
Dadras O, SeyedAlinaghi S, Karimi A, Shamsabadi A, Qaderi K, Ramezani M
Health Sci Rep. 2022; 5(3):e657.
PMID: 35620541
PMC: 9125886.
DOI: 10.1002/hsr2.657.
Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants in Germany.
Kuhn M, Abele D, Binder S, Rack K, Klitz M, Kleinert J
BMC Infect Dis. 2022; 22(1):333.
PMID: 35379190
PMC: 8978163.
DOI: 10.1186/s12879-022-07302-9.
Trends in outcomes following COVID-19 symptom onset in Milan: a cohort study.
Jackson C, Grosso F, Kunzmann K, Corbella A, Gramegna M, Tirani M
BMJ Open. 2022; 12(3):e054859.
PMID: 35332039
PMC: 8948075.
DOI: 10.1136/bmjopen-2021-054859.
Simpson's Paradox in COVID-19 Case Fatality Rates: A Mediation Analysis of Age-Related Causal Effects.
von Kugelgen J, Gresele L, Scholkopf B
IEEE Trans Artif Intell. 2022; 2(1):18-27.
PMID: 35233556
PMC: 8791436.
DOI: 10.1109/TAI.2021.3073088.
Data-driven case fatality rate estimation for the primary lineage of SARS-CoV-2 in Poland.
Gogolewski K, Miasojedow B, Sadkowska-Todys M, Stepien M, Demkow U, Lech A
Methods. 2022; 203:584-593.
PMID: 35085741
PMC: 8785264.
DOI: 10.1016/j.ymeth.2022.01.006.
Model-based evaluation of alternative reactive class closure strategies against COVID-19.
Liu Q, Zhang J, Peng C, Litvinova M, Huang S, Poletti P
Nat Commun. 2022; 13(1):322.
PMID: 35031600
PMC: 8760266.
DOI: 10.1038/s41467-021-27939-5.
A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden.
Zardini A, Galli M, Tirani M, Cereda D, Manica M, Trentini F
Epidemics. 2021; 37:100530.
PMID: 34826786
PMC: 8595250.
DOI: 10.1016/j.epidem.2021.100530.
Estimation of viral kinetics model parameters in young and aged SARS-CoV-2 infected macaques.
Rodriguez T, Dobrovolny H
R Soc Open Sci. 2021; 8(11):202345.
PMID: 34804559
PMC: 8595996.
DOI: 10.1098/rsos.202345.
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave.
Davis J, Chinazzi M, Perra N, Mu K, Pastore Y Piontti A, Ajelli M
Nature. 2021; 600(7887):127-132.
PMID: 34695837
PMC: 8636257.
DOI: 10.1038/s41586-021-04130-w.
Hydrogel-Based Slow Release of a Receptor-Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS-CoV-2.
Gale E, Powell A, Roth G, Meany E, Yan J, Ou B
Adv Mater. 2021; 33(51):e2104362.
PMID: 34651342
PMC: 8646307.
DOI: 10.1002/adma.202104362.
Changes in severity, mortality, and virus genome among a Spanish cohort of patients hospitalized with SARS-CoV-2.
Aznar-Gimeno R, Pano-Pardo J, Esteban L, Labata-Lezaun G, Esquillor-Rodrigo M, Lanas A
Sci Rep. 2021; 11(1):18844.
PMID: 34552127
PMC: 8458298.
DOI: 10.1038/s41598-021-98308-x.